An anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut-lung axis and NLRP3 inflammasome activation.
10.1016/j.apsb.2025.04.008
- Author:
Xinxing LI
1
;
Wenxin DING
2
;
Yan LU
1
;
Haiyan ZHU
2
;
Weilian BAO
1
;
Yang LIU
1
;
Jiaren LYU
1
;
Lishuang ZHOU
1
;
Hong LI
3
;
Jiyang LI
2
;
Daofeng CHEN
1
Author Information
1. Department of Natural Medicine, School of Pharmacy, Fudan University, Shanghai 201203, China.
2. Department of Biological Medicines, School of Pharmacy, Fudan University, Shanghai 201203, China.
3. Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai 201203, China.
- Publication Type:Journal Article
- Keywords:
Complement;
Gut-lung axis;
H1N1;
Houttuynia cordata;
MRSA;
NLRP3;
Pneumonia;
Polysaccharides;
Treg/Th17 cell balance
- From:
Acta Pharmaceutica Sinica B
2025;15(6):3073-3091
- CountryChina
- Language:English
-
Abstract:
The coinfection of respiratory viruses and bacteria is a major cause of morbidity and mortality worldwide, despite the development of vaccines and powerful antibiotics. As a macromolecule that is difficult to absorb in the gastrointestinal tract, a homogeneous polysaccharide from Houttuynia cordata (HCPM) has been reported to exhibit anti-complement properties and alleviate influenza A virus (H1N1)-induced lung injury; however, the effects of HCPM without in vitro antiviral and antibacterial activities on more complicated pulmonary diseases resulting from viral-bacterial coinfection remains unclear. This study established a representative coinfection murine pneumonia model infected with H1N1 (0.2 LD50) and methicillin-resistant Staphylococcus aureus (MRSA, 107 CFU). HCPM significantly improved survival rate and weight loss, and ameliorated gut-lung damage and inflammatory cytokine production. Interestingly, the therapeutic effect of HCPM on intestinal damage preceded that in the lungs. Mechanistically, HCPM inhibited the overactivation of the intestinal complement (C3a and C5a) and suppressed the activation of the NLR family pyrin domain-containing 3 (NLRP3) pathway, which contributes to the regulation of the Treg/Th17 cell balance in the gut-lung axis. The results indicate the beneficial effects of an anti-complement polysaccharide against viral-bacterial coinfection pneumonia by modulating crosstalk between multiple immune regulatory networks.
